Helen Elizabeth Hanby
Direttore/Membro del Consiglio presso NIGHTSTAR THERAPEUTICS PLC
Posizioni attive di Helen Elizabeth Hanby
Società | Posizione | Inizio | Fine |
---|---|---|---|
NIGHTSTAR THERAPEUTICS PLC | Direttore/Membro del Consiglio | 07/06/2019 | - |
Segretario Aziendale | 08/08/2019 | - | |
Tungsten Bidco Ltd.
Tungsten Bidco Ltd. Financial ConglomeratesFinance Founded in 2019, Tungsten Bidco Ltd. is a British company that functions as an investment holding company. Part of Biogen, Inc., the company is based in Maidenhead, UK. | Direttore/Membro del Consiglio | 04/06/2019 | - |
Segretario Aziendale | 08/08/2019 | - | |
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 07/06/2019 | - |
Segretario Aziendale | 08/08/2019 | - |
Storia della carriera di Helen Elizabeth Hanby
Statistiche
Distribuzione geografica
Regno Unito | 4 |
Posizioni
Director/Board Member | 3 |
Corporate Secretary | 3 |
Settori
Health Technology | 2 |
Finance | 2 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
Nightstar Therapeutics Ltd.
Nightstar Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nightstar Therapeutics Ltd. is a clinical-stage gene therapy. It engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. The company was founded by Robert MacLaren, Miguel Seabra and Matthew During in 2014 and is headquartered in London, the United Kingdom. | Health Technology |
Tungsten Bidco Ltd.
Tungsten Bidco Ltd. Financial ConglomeratesFinance Founded in 2019, Tungsten Bidco Ltd. is a British company that functions as an investment holding company. Part of Biogen, Inc., the company is based in Maidenhead, UK. | Finance |
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Health Services |